AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study

NCT05754424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: AT278
DRUG: NovoRapid
DRUG: Humulin R 500 UNT/ML Injectable Solution

Sponsor

Arecor Limited